Skip to main content
. 2017 Nov 27;8(65):109596–109608. doi: 10.18632/oncotarget.22741

Figure 1. In vitro Cisplatin resistance of Cisplatin-selected SCLC cells.

Figure 1

(A) Cytotoxic effects of Cisplatin in the H69 cells and the SCLC cells from Cisplatin-treated mice. (B) Average IC50s of Cisplatin in H69 cells and in SCLC cells from Cisplatin-treated mice. (C) Morphology of H69 and CRSC cells (×200). (D) Immunoblot analysis of apoptotic markers during Cisplatin treatment in H69 and CRSC cells. (**, P < 0.01).